Huo said their results may someday be used to change treatment guidelines for stroke survivors who have undergone successful clot removal. "We still need to directly analyze the individual data of ...

Imperative Care has completed subject enrolment in the pivotal investigational device exemption (IDE) trial, SYMPHONY-PE, assessing the Symphony thrombectomy system's efficacy and safety in treating ...

As strokes remain a leading cause of death and long-term disability worldwide, the demand for effective clot removal techniques is growing steadily. This, in turn, is accelerating investments in ...

Symphony Thrombectomy System is designed to efficiently maximize clot removal with a focus on minimizing blood loss Imperative Care, Inc. today announced U.S. Food and Drug Administration (FDA ...

In January 2013, Varejão, then 30 years old and playing for the Cleveland Cavaliers, was hospitalized with a blood clot in his left lung. The pulmonary embolism was discovered after Varejão told ...